| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +100.00% | +24.86% | +3.00% | +21.87% | +20.05% | — |
| 14d | 3 | +100.00% | +21.38% | +3.78% | +17.60% | +16.47% | — |
| 30d | 3 | +100.00% | +71.93% | +3.17% | +68.77% | +65.72% | — |
| 60d | 3 | +100.00% | +113.74% | +4.33% | +109.41% | +109.27% | — |
| 90d | 3 | +100.00% | +65.04% | +3.89% | +61.15% | +58.95% | — |
| 180d | 3 | +100.00% | +58.91% | +12.75% | +46.16% | +45.12% | — |
| 1y | 3(3 pending) | — | — | — | — | — | — |
| 2y | 3(3 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| TENX TENAX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 450,000 | — | — | 450,000 | Jan 9, 2026 | Jan 13, 2026 ↗ | View → |
| TENX TENAX THERAPEUTICS, INC. | PURCHASE CEO | 538 | $7.59 | $4.1K | 2,605 | Nov 20, 2025 | Nov 20, 2025 ↗ | View → |
| TENX TENAX THERAPEUTICS, INC. | PURCHASE CEO | 455 | $7.51 | $3.4K | 2,067 | Nov 19, 2025 | Nov 20, 2025 ↗ | View → |
| TENX TENAX THERAPEUTICS, INC. | PURCHASE CEO | 1,612 | $7.75 | $12.5K | 1,612 | Nov 18, 2025 | Nov 20, 2025 ↗ | View → |
| TENX TENAX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,400,000 | — | — | 1,400,000 | May 16, 2025 | May 20, 2025 ↗ | View → |
| TENX TENAX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,250,000 | — | — | 1,250,000 | Dec 10, 2024 | Dec 12, 2024 ↗ | View → |
| TENX TENAX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 437 | — | — | 437 | May 17, 2024 | May 21, 2024 ↗ | View → |
| TENX TENAX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Jun 9, 2022 | Jun 10, 2022 ↗ | View → |